Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
06/2012
06/28/2012US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/28/2012US20120165339 Cyclopropane derivatives
06/28/2012US20120164102 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
06/28/2012CA2821225A1 Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
06/27/2012EP2468729A1 Novel indazole derivative
06/27/2012EP2468728A1 2-(1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-YL)ethylamine derivatives useful as sigma receptor inhibitors
06/27/2012EP2468717A1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
06/27/2012EP2467367A1 3-triazolylphenyl-substituted sulfide derivatives for use as acaricides and insecticides
06/27/2012EP1984340B1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
06/27/2012EP1562909B1 Ophthalmic compositions for treating ocular hypertension
06/27/2012CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
06/27/2012CN102516176A Indazole derivatives that inhibit TRPVL receptor
06/27/2012CN102516175A Process for the production of pyrazoles
06/27/2012CN102516174A Poly-substituted pyrazoline compound and preparation method thereof
06/27/2012CN102516155A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/27/2012CN102515996A Novel method for synthesizing beta-aryl acrylamide compound
06/27/2012CN101973934B 1,5-disubstituted aryl-1,4-pentadiene-3-ketoxime ether compound and preparation method thereof and insecticidal activity application
06/27/2012CN101541755B Benzoylpyrazole compounds, process for their production and herbicides containing them
06/27/2012CN101501002B Non-nucleoside reverse transcriptase inhibitors
06/27/2012CN101367763B Synthesis process of 1-phenyl-3-methyl-5-pyrazolone
06/27/2012CN101360730B Fungicide N-cycloalkyl-benzyl-amide derivatives
06/26/2012US8207354 Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
06/26/2012US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors
06/26/2012US8207210 Aminoindazolylurea derivatives
06/26/2012US8207166 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012WO2012083306A2 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012WO2012082857A1 Neprilysin inhibitors
06/21/2012WO2012082853A1 Neprilysin inhibitors
06/21/2012WO2012082633A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012WO2012081916A2 Indazole derivative and a pesticide composition containing the same
06/21/2012WO2012080286A2 Dyeing composition comprising a heterocyclic oxidation base and a cationic 3,5-diaminopyridine coupler
06/21/2012WO2011051540A9 Androgen receptor modulating compounds
06/21/2012US20120157414 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012CA2819153A1 Neprilysin inhibitors
06/21/2012CA2817368A1 Neprilysin inhibitors
06/20/2012EP2465851A1 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
06/20/2012EP2465850A1 Therapeutic compounds
06/20/2012EP2464630A2 Microbiocidal heterocycles
06/20/2012EP2464231A1 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
06/20/2012EP2297111B1 Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters
06/20/2012EP2102169B1 Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/20/2012EP1963276B1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
06/20/2012EP1305292B1 Biphenyl carboxamides
06/20/2012CN102503945A Compound capable of inhibiting epidermal growth factor receptor and application thereof
06/20/2012CN102503891A Pyrazole derivatives as 11-beta-hsd1 inhibitors
06/20/2012CN101384556B Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
06/19/2012US8203004 Tetrahydroindole derivatives for treatment of alzheimer's disease
06/19/2012US8202899 Pyrazole urea derivatives used as kinase inhibitors
06/19/2012US8202894 Microbiocides
06/19/2012US8202878 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease;Trans [4-(4-{3-[2-(1-adamantyl)-2-hydroxyethoxy]-1H-pyrazol-5-yl}phenyl)cyclohexyl]acetic acid
06/19/2012US8202876 Compounds and compositions as protein kinase inhibitors
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/14/2012WO2012078817A1 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
06/14/2012WO2012078593A2 Lysophosphatidic acid receptor antagonists and uses thereof
06/14/2012US20120149912 Process for the preparation of 1-benzyl-3-hydroxymethyl-1h-indazole and its derivatives and required magnesium intermediates
06/14/2012US20120149910 Pesticidal Carboxamides
06/14/2012US20120149750 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
06/14/2012US20120149741 Treatment of duchenne muscular dystrophy
06/14/2012US20120149710 Sortase a inhibitors
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120146015 Charge transport materials for luminescent applications
06/14/2012CA2820817A1 Lysophosphatidic acid receptor antagonists and uses thereof
06/14/2012CA2820065A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/13/2012EP2463278A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462119A1 Process for the preparation of 1-benzyl-3-hydr0xymethyl-1h-indaz0le and its derivatives and required magnesium intermediates
06/13/2012EP2462118A1 Process for the preparation of 1-benzyl-3-hydroxymethyl- 1h- indazole and its derivatives and required magnesium intermediates
06/13/2012EP2462108A1 Process for the preparation of pyrazole carboxylic acid amides
06/13/2012EP2023920B1 Cannabinoid receptor antagonists/inverse agonists
06/13/2012EP1979311B1 Phenoxy acetic acids as ppar delta activators
06/13/2012EP1854788B1 Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
06/13/2012EP1618087B1 Antibacterial agents
06/13/2012CN101701010B Pyrazole compound
06/13/2012CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof
06/13/2012CN101460466B Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
06/13/2012CN101410375B Method for producing aromatic compound
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198458 Non-nucleoside reverse transcriptase inhibitors
06/12/2012US8198454 Amide derivatives and medicinal use thereof
06/12/2012US8198323 Curcumin analogues and uses thereof
06/12/2012US8198311 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
06/12/2012US8198309 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides
06/12/2012CA2662242C Benzo-fused compounds for use in treating metabolic disorders
06/12/2012CA2659471C Novel crystals of substituted phenylalkanoic acid and method of producing the same
06/12/2012CA2658523C Inhibitors of plasma kallikrein
06/07/2012WO2012074067A1 Pyrazole compound having therapeutic effect on multiple myeloma
06/07/2012WO2012072791A2 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors
06/07/2012US20120142937 Method for coupling halogen-substituted aromatic compounds with organic compounds comprising trialkylsilyl-substituted heteroatoms
06/07/2012US20120142915 Cyclopropyl mida boronate
06/07/2012US20120142714 Bicyclic compound
06/07/2012US20120142702 Integrin-linked kinase inhibitors
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142668 Cathepsin c inhibitors
06/07/2012CA2819215A1 Pyrazole compounds having therapeutic effect on multiple myeloma
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 256